Fragment-Based Stabilizers of Protein-Protein Interactions through Imine-Based Tethering

被引:46
|
作者
Wolter, Madita [1 ,2 ]
Valenti, Dario [1 ,2 ,3 ]
Cossar, Peter J. [1 ,2 ]
Levy, Laura M. [3 ]
Hristeva, Stanimira [3 ]
Genski, Thorsten [3 ]
Hoffmann, Torsten [3 ]
Brunsveld, Luc [1 ,2 ]
Tzalis, Dimitrios [3 ]
Ottmann, Christian [1 ,2 ,4 ]
机构
[1] Eindhoven Univ Technol, Dept Biomed Engn, Biol Chem Lab, POB 513, NL-5600 MB Eindhoven, Netherlands
[2] Eindhoven Univ Technol, Inst Complex Mol Syst, POB 513, NL-5600 MB Eindhoven, Netherlands
[3] Taros Chem GmbH & Co KG, Emil Figge Str 76a, D-44227 Dortmund, Germany
[4] Univ Duisburg Essen, Dept Chem, Univ Str 7, D-45117 Essen, Germany
基金
欧盟地平线“2020”;
关键词
14-3-3; proteins; cooperative effects; fragment-based drug discovery; imine chemistry; protein-protein interactions; DRUG DISCOVERY; TARGETS;
D O I
10.1002/anie.202008585
中图分类号
O6 [化学];
学科分类号
0703 ;
摘要
Small-molecule stabilization of protein-protein interactions (PPIs) is a promising concept in drug discovery, however the question how to identify or design chemical starting points in a "bottom-up" approach is largely unanswered. We report a novel concept for identifying initial chemical matter for PPI stabilization based on imine-forming fragments. The imine bond offers a covalent anchor for site-directed fragment targeting, whereas its transient nature enables efficient analysis of structure-activity relationships. This bond enables fragment identification and optimisation using protein crystallography. We report novel fragments that bind specifically to a lysine at the PPI interface of the p65-subunit-derived peptide of NF-kappa B with the adapter protein 14-3-3. Those fragments that subsequently establish contacts with the p65-derived peptide, rather than with 14-3-3, efficiently stabilize the 14-3-3/p65 complex and offer novel starting points for molecular glues.
引用
收藏
页码:21520 / 21524
页数:5
相关论文
共 50 条
  • [1] Using Fragment-Based Technologies to Target Protein-Protein Interactions
    Bower, Justin F.
    Pannifer, Andrew
    CURRENT PHARMACEUTICAL DESIGN, 2012, 18 (30) : 4685 - 4696
  • [2] Using a Fragment-Based Approach To Target Protein-Protein Interactions
    Scott, Duncan E.
    Ehebauer, Matthias T.
    Pukala, Tara
    Marsh, May
    Blundell, Tom L.
    Venkitaraman, Ashok R.
    Abell, Chris
    Hyvoenen, Marko
    CHEMBIOCHEM, 2013, 14 (03) : 332 - 342
  • [3] Targeting Protein-Protein Interactions and Fragment-Based Drug Discovery
    Valkov, Eugene
    Sharpe, Tim
    Marsh, May
    Greive, Sandra
    Hyvoenen, Marko
    FRAGMENT-BASED DRUG DISCOVERY AND X-RAY CRYSTALLOGRAPHY, 2012, 317 : 145 - 179
  • [4] Site-Directed Fragment-Based Screening for the Discovery of Protein-Protein Interaction Stabilizers
    Sijbesma, Eline
    Hallenbeck, Kenneth K.
    Leysen, Seppe
    de Vink, Pim J.
    Skora, Lukasz
    Jahnke, Wolfgang
    Brunsyeld, Luc
    Arkin, Michelle R.
    Ottmann, Christian
    JOURNAL OF THE AMERICAN CHEMICAL SOCIETY, 2019, 141 (08) : 3524 - 3531
  • [5] Clinical candidates modulating protein-protein interactions: The fragment-based experience
    Valenti, Dario
    Hristeva, Stanimira
    Tzalis, Dimitrios
    Ottmann, Christian
    EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2019, 167 : 76 - 95
  • [6] Fragment-Based Protein-Protein Interaction Antagonists of a Viral Dimeric Protease
    Gable, Jonathan E.
    Lee, Gregory M.
    Acker, Timothy M.
    Hulce, Kaitlin R.
    Gonzalez, Eric R.
    Schweigler, Patrick
    Melkko, Samu
    Farady, Christopher J.
    Craik, Charles S.
    CHEMMEDCHEM, 2016, 11 (08) : 862 - 869
  • [7] From Tethered to Freestanding Stabilizers of 14-3-3 Protein-Protein Interactions through Fragment Linking
    Visser, Emira J.
    Jaishankar, Priyadarshini
    Sijbesma, Eline
    Pennings, Marloes A. M.
    Vandenboorn, Edmee M. F.
    Guillory, Xavier
    Neitz, R. Jeffrey
    Morrow, John
    Dutta, Shubhankar
    Renslo, Adam R.
    Brunsveld, Luc
    Arkin, Michelle R.
    Ottmann, Christian
    ANGEWANDTE CHEMIE-INTERNATIONAL EDITION, 2023, 62 (37)
  • [8] Targeting YAP/TAZ-TEAD protein-protein interactions using fragment-based and computational modeling approaches
    Kaan, Hung Yi Kristal
    Sim, Adelene Y. L.
    Tan, Siew Kim Joyce
    Verma, Chandra
    Song, Haiwei
    PLOS ONE, 2017, 12 (06):
  • [9] Fragment-Based Interrogation of the 14-3-3/TAZ Protein-Protein Interaction
    Andlovic, Blaz
    Valenti, Dario
    Centorrino, Federica
    Picarazzi, Francesca
    Hristeva, Stanimira
    Hiltmann, Malgorzata
    Wolf, Alexander
    Cantrelle, Francois-Xavier
    Mori, Mattia
    Landrieu, Isabelle
    Levy, Laura M.
    Klebl, Bert
    Tzalis, Dimitrios
    Genski, Thorsten
    Eickhoff, Jan
    Ottmann, Christian
    BIOCHEMISTRY, 2024, 63 (17) : 2196 - 2206
  • [10] Probing the druggability of protein-protein interactions: targeting the Notch1 receptor ankyrin domain using a fragment-based approach
    Abdel-Rahman, Noha
    Martinez-Arias, Alfonso
    Blundell, Tom L.
    BIOCHEMICAL SOCIETY TRANSACTIONS, 2011, 39 : 1327 - 1333